Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
2,116,135
-
Share change
-
+504,662
-
Total reported value
-
$38,049,726
-
Price per share
-
$17.98
-
Number of holders
-
18
-
Value change
-
+$9,088,347
-
Number of buys
-
14
-
Number of sells
-
1
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q3 2020
As of 30 Sep 2020,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,116,135 shares.
The largest 10 holders included
CITIGROUP INC, The PNC Financial Services Group, Inc., UBS Group AG, Mirae Asset Global Investments Co., Ltd., SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC, PROEQUITIES, INC., ROYAL BANK OF CANADA, ADVISOR GROUP HOLDINGS, INC., and American Portfolios Advisors.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.